Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD - Mayo Clinic
4.9
$ 7.00
In stock
(478)
Product Description
Crohn's disease Nature Reviews Disease Primers
Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches - Giuseppe Privitera, Daniela Pugliese, Loris Riccardo Lopetuso, Franco Scaldaferri, Matteo Neri, Luisa Guidi, Antonio Gasbarrini, Alessandro Armuzzi, 2021
Is miR-223 Upregulation in Inflammatory Bowel Diseases a Protective Response ?
(PDF) Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations
Intestinal Research
Vedolizumab for the treatment of ulcerative colitis and Crohn's disease
Digestive Diseases News - Medical Professionals - Mayo Clinic
Benefit-Risk Paradigm With Conventional and Biologic Tx (Slides/Transcript)
Multi-omics in Crohn's disease: New insights from inside - Computational and Structural Biotechnology Journal
Virtual IBD Clinic: Updates in Diagnostic Strategies
Frontiers Artificial Intelligence Enhances Studies on Inflammatory Bowel Disease
Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease - ScienceDirect
Full article: Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease
Inflammatory bowel disease and psoriasis: modernizing the multidisciplinary approach - Hedin - 2021 - Journal of Internal Medicine - Wiley Online Library
/cdn.vox-cdn.com/uploads/chorus_image/image/42615382/20141023_ajw_ac4_347.JPG.0.jpg "Broncos vs. Chargers earn second-highest TNF rating of all-time")
